Related Experiment Video
Updated: Aug 5, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
miR-27b-3p aggravates steatohepatitis progression by targeting the Nrf2/HO-1 pathway
Kui Wang1, Hao Pan1, Yan Tian1
1College of Veterinary Medicine, Yunnan Agricultural University, Kunming, China.
Animal Bioscience
|July 29, 2026
Summary
MicroRNA-27b-3p exacerbates fatty liver by targeting Nrf2, increasing oxidative stress and inflammation. Inhibiting miR-27b-3p shows potential for treating bovine fatty liver disease.
Area of Science:
- Molecular Biology
- Biochemistry
- Animal Science
Background:
- Fatty liver disease is characterized by lipid accumulation, oxidative stress, and inflammation.
- The Nrf2/HO-1 signaling pathway plays a crucial role in cellular defense against oxidative stress.
- The role of microRNAs in regulating fatty liver progression and associated cellular responses remains incompletely understood.
Purpose of the Study:
- To investigate the regulatory role of miR-27b-3p in oxidative stress and inflammation during fatty liver progression.
- To elucidate the involvement of the Nrf2/HO-1 signaling pathway in miR-27b-3p-mediated effects on fatty liver.
- To determine if miR-27b-3p directly targets Nrf2.
Main Methods:
- Analysis of liver tissues from dairy cows with fatty liver and high-fat diet-induced fatty liver in mice.
- Establishment of an in vitro steatosis model using palmitic acid-treated AML-12 hepatocytes.
- Assessment of oxidative stress markers, inflammatory cytokines, and apoptosis-related proteins.
- Bioinformatic prediction and dual-luciferase reporter assays to confirm miR-27b-3p targeting of Nrf2.
- Gain- and loss-of-function experiments utilizing miR-27b-3p mimics and inhibitors.
Main Results:
- Fatty liver tissues showed increased miR-27b-3p expression and suppressed Nrf2/HO-1 signaling.
- miR-27b-3p directly binds to the 3' untranslated region of Nrf2.
- Inhibition of miR-27b-3p restored Nrf2/HO-1 expression, reduced oxidative stress and inflammation, and alleviated apoptosis.
- Overexpression of miR-27b-3p exacerbated these detrimental effects.
Conclusions:
- miR-27b-3p promotes fatty liver progression to steatohepatitis by targeting Nrf2 and inhibiting the Nrf2/HO-1 pathway.
- This leads to enhanced oxidative stress, inflammation, and hepatocyte apoptosis in fatty liver.
- Targeting miR-27b-3p presents a potential therapeutic strategy for bovine fatty liver disease.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...